Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Scorpion Venom Could Improve Immuno-Oncology Therapies in Brain Cancer
BioSpace
Thu, 03/5/20 - 10:49 am
brain cancer
drug development
CAR-T
City of Hope
scorpion venom
Morphosys’ off-the-shelf rival to CAR-T approaches finish line with a speedy review
Endpoints
Mon, 03/2/20 - 09:37 am
MorphoSys
Gilead Sciences
Novartis
CAR-T
tafasitamab
DLBCL
Cellectis boosts its coffers in revised off-the-shelf CAR-T deal with Servier
Endpoints
Wed, 02/19/20 - 09:56 am
CAR-T
Cellectis
Servier
UCART19
Bristol-Myers' CAR-T gets priority review, mid-August PDUFA date
Fierce Biotech
Thu, 02/13/20 - 11:04 am
Bristol-Myers Squibb
FDA
lisocabtagene maraleucel
priority review
CAR-T
Gilead closes in on second CAR-T approval in US
Pharmaforum
Tue, 02/11/20 - 10:30 am
FDA
Gilead Sciences
Kite Pharma
mantle cell lymphoma
CAR-T
CAR-T tackles multiple myeloma by using the target CD229 to kill cancer stem cells
Fierce Biotech
Mon, 02/10/20 - 10:11 am
CAR-T
Multiple Myeloma
CD229
JNJ
Bluebird Bio
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial
Xconomy
Fri, 02/7/20 - 10:23 am
Scripps Research Institute
Calibr
CAR-T
MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner
Endpoints
Thu, 02/6/20 - 11:50 am
Takeda
MD Anderson
natural killer cell therapy
CAR-T
Adaptimmune and Astellas to Co-Develop Allogenic CAR-T and TCR T-Cell Therapies
BioSpace
Tue, 01/14/20 - 10:46 am
Adaptimmune
SPEAR-T
Astellas
CAR-T
cell therapy
drug development
Merck-partnered biotech hands Roche its half-life extension tech as it pivots to immuno-oncology
Endpoints
Fri, 01/10/20 - 10:21 am
Roche
immuno-oncology
Amunix
Merck
CAR-T
Docs are excited about CAR-T, BTK drugs, survey finds. How can pharma best promote them?
Fierce Pharma
Tue, 01/7/20 - 11:11 pm
physicians
oncologists
Multiple Myeloma
CAR-T
Bristol-Myers unloads old-school plant as it readies for CAR-T future
Fierce Pharma
Tue, 01/7/20 - 10:47 pm
Bristol-Myers Squibb
Celgene
CAR-T
M&A
3 trends in biotech to watch in 2020
Stat
Mon, 12/30/19 - 10:34 am
IPOs
eteplirsen
CAR-T
gene therapy
cell therapy
biotech
Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles
Fierce Pharma
Thu, 12/19/19 - 01:11 pm
gene therapy
reimbursement
drug manufacturing
Bristol-Myers Squibb
Pfizer
Biomarin
Sarepta Therapeutics
Gilead Sciences
CAR-T
Anixa delays CAR-T trial in bid to boost efficacy
Fierce Biotech
Fri, 12/13/19 - 11:00 am
Anixa Biosciences
ovarian cancer
CAR-T
Gilead's Kite files for FDA approval of second CAR-T therapy
Fierce Biotech
Thu, 12/12/19 - 11:27 am
Gilead Sciences
KTE-X19
mantle cell lymphoma
CAR-T
Kite Pharma
Novartis still hasn't solved its lingering CAR-T manufacturing issues
Biopharma Dive
Wed, 12/11/19 - 09:59 pm
ASH2019
Novartis
FDA
CAR-T
drug manufacturing
Kymriah
Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting
Pharmaceutical Business Review
Tue, 12/10/19 - 10:06 am
Novartis
Kymriah
CAR-T
DLBCL
ALL
ASH: Gilead touts 'astounding' Yescarta survival results at 3 years
Fierce Pharma
Sun, 12/8/19 - 10:13 pm
Gilead Sciences
Yescarta
ASH2019
CAR-T
refractory large B-cell lymphoma
2 Small-Cap Biotechs That Soared Last Week
Motley Fool
Tue, 11/26/19 - 09:42 am
Magenta Therapeutics
Molecular Templates
gene therapy
CAR-T
cancer
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »